Filing Details
- Accession Number:
- 0000899243-22-029840
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-26 16:06:10
- Reporting Period:
- 2022-08-24
- Accepted Time:
- 2022-08-26 16:06:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1796129 | Vincerx Pharma Inc. | VINC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376260 | P. Christopher Lowe | 260 Sheridan Avenue, Suite 400 Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-24 | 18,400 | $1.65 | 28,400 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-25 | 11,600 | $1.65 | 40,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price. Actual purchase prices ranged from $1.638 to $1.649 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
- Represents a weighted average purchase price. Actual purchase prices ranged from $1.6499 to $1.65 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.